Watch the interesting webinar on personalised medicine organized by Myeloma Patients Europe (MPE). In this webinar, Dr Annemiek Broijl from the Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands – provided examples of the individualized therapy options including future developments such as the MMpredict project.
- Dr. Annemieke Van Dongen-Leunis from the Erasmus School of Health Policy and Management, explains the main results of two posters presented during the 24th European Hematology Association congress
- Webinar on personalised medicine in multiple myeloma
- Fifth H2020 MMpredict consortium meeting in Amsterdam
- The project consortium completed the second periodic report
- A subsequent milestone in the Horizon2020 project is reached